Empirical Wealth Management’s Ovid Therapeutics OVID Stock Holding History

Empirical Wealth Management’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$32K	Buy	+12,849	New	+$33.6K	﹤0.01%	1148

Other funds holding OVID

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Total Clarity Wealth Management St. Charles, Illinois $518M AUM 17.26% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Benin Management Corp Wilton, Connecticut $517M AUM 21.33% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Empirical Wealth Management's OVID Position: Q3 2026 in Review

Empirical Wealth Management opened a new position in Ovid Therapeutics (OVID) in Q3 2026: 12,849 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #1148 among its holdings.

17 funds tracked by Wall St. Rank hold OVID as of Q3 2026.

Empirical Wealth Management held 12,849 shares of Ovid Therapeutics worth $32K as of Q3 2026.
Ovid Therapeutics was a new Empirical Wealth Management position in Q3 2026.
Ovid Therapeutics made up ﹤0.01% of Empirical Wealth Management's portfolio in Q3 2026, its #1148 holding.
17 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.

Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.